Daniel Kiss, MD
Interventional Cardiology · Eatontown, NJNPI 1124311642
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Shockwave Medical, Inc at 48.1% of the total. 2025 is the largest year on record at $71,128, more than ten times the $1,267 reported in 2019. Among interventional cardiology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 750 payments — averaging $229.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$83K
- Abbott$78K
- Medtronic$4K
- Edwards Lifesciences$2K
- Boston Scientific$2K
- Abiomed$1K
- plus $3K from 29 others
What the payments were for
- Consulting fees$78,37545%
- Speaking & faculty fees$50,95030%
- Travel & lodging$23,79814%
- Food & beverage$19,24611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 86 | $82,885 |
| Abbott | 248 | $77,562 |
| Medtronic(2 entities) | 72 | $4,154 |
| Edwards Lifesciences | 33 | $1,933 |
| Boston Scientific | 183 | $1,748 |
| Abiomed | 21 | $1,232 |
| AstraZeneca | 9 | $461 |
| Novartis | 17 | $307 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $247 |
| Pfizer | 12 | $192 |
| Acist Medical Systems, Inc. | 2 | $165 |
| Amgen | 9 | $164 |
| E.r. Squibb & Sons, L.L.C. | 5 | $152 |
| Siemens Medical Solutions USA, Inc. | 2 | $152 |
| Penumbra, Inc. | 1 | $130 |
| W. L. Gore & Associates, Inc. | 3 | $125 |
| Johnson & Johnson | 4 | $109 |
| Cardiovascular Systems Inc. | 4 | $90 |
| Terumo Medical Corporation | 2 | $57 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| Bridgebio Pharma, Inc. | 3 | $54 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Heartflow, Inc. | 2 | $38 |
| Cardinal Health 200 LLC | 2 | $35 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $34 |
| Kestra Medical Technology Services, Inc. | 2 | $33 |
| Chiesi USA, Inc. | 2 | $32 |
| Novo Nordisk | 2 | $32 |
| Cleerly, Inc. | 1 | $28 |
| Boehringer Ingelheim | 2 | $27 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Daxor Corporation | 1 | $20 |
| GE HealthCare | 1 | $17 |
| Cardiva Medical, Inc. | 1 | $16 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$81,718
- OPTIS$35,035
- DRAGONFLY OPSTAR$24,851
- Dragonfly OCT$6,473
- XIENCE V$3,500
- MitraClip$1,546
- COREVALVE EVOLUT R$914
- Perclose ProStyle$912
- CoreValve Evolut$475
- Optis Coronary Imaging System$399
- Impella$394
- EVOQUE$377
- SYMPLICITY G3$299
- Edwards SAPIEN 3 Transcatheter Heart Valve$249
- QUADRA ASSURA$182
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$163
- RESOLUTE ONYX$155
- CVI SYSTEMS$140
- Xience Sierra Coronary Stent System$140
- ARTIS icono biplane$133
How this compares
$172,370 in reported general payments places this provider in the 95th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 260 | $307,384 |
| XareltoRivaroxaban | 84 | $93,196 |
| EntrestoSacubitril/Valsartan | 50 | $80,961 |
| Repatha SureclickEvolocumab | 60 | $56,861 |
| FarxigaDapagliflozin Propanediol | 31 | $47,633 |
| MultaqDronedarone Hcl | 19 | $32,006 |
| BrilintaTicagrelor | 17 | $19,473 |
| Praluent PenAlirocumab | 17 | $15,073 |
| JardianceEmpagliflozin | 17 | $10,805 |
| Rosuvastatin Calcium | 492 | $7,011 |
| Ranolazine ErRanolazine | 36 | $5,969 |
| Valsartan | 128 | $5,538 |
| Ezetimibe | 204 | $5,516 |
| Metoprolol Succinate | 282 | $5,259 |
| Atorvastatin Calcium | 487 | $5,005 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $192 | $307,384260 claims |
| Johnson & JohnsonXarelto | $109 | $93,19684 claims |
| NovartisEntresto | $307 | $80,96150 claims |
| AstraZenecaFarxiga, Brilinta | $461 | $67,10648 claims |
| Sanofi-aventis U.S. LLCMultaq | $48 | $32,00619 claims |
| Boehringer IngelheimJardiance | $27 | $10,80517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 166 interventional cardiology providers in New Jersey.
Other interventional cardiology in Eatontown
- Matthew SayboltEatontown$175K
- Isaac TawfikEatontown$23K
- David AnwarEatontown$12K
- Ankitkumar PatelGlen Ridge$408K
- Ziad AbbudOcean$360K
- Ramin HastingsHasbrouck Heights$295K
- Michael LimHackensack$215K
- Darshan GodkarCedar Knolls$194K
- Ryan KapleHackensack$178K
- Kintur SanghviBordentown$139K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.